-
-
-
-
-
-
-
Psyence BioMed settles shareholder litigation for $1.5 million
-
-
-
-
-
-
-
Psyence BioMed partner produces high-purity ibogaine extract
-
-
-
-
-
-
-
Psyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock Split
-
-
-
-
-
-
-
Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein
-
-
-
-
-
-
-
Psyence Biomedical (PBM) Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
-
-
-
-
-
457,893 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

